Full-Time
Data Engineer
Posted on 7/29/2025
Pattern Bioscience
51-200 employees
AI-driven rapid bacterial ID and AST
No salary listed
Pune, Maharashtra, India
Hybrid
 Data & Analytics (1) |
|---|
- Bachelor’s Degree in Data Science, Data Analytics, Information Management, Computer Science, Information Technology, related field, or equivalent professional experience
- Overall experience should be more than 4 + years
- 3+ years of experience working with SQL
- 3+ years of experience in implementing modern data architecture-based data warehouses
- 2+ years of experience working with data warehouses such as Redshift, BigQuery, or Snowflake and understand data architecture design
- Excellent software engineering and scripting knowledge
- Strong communication skills (both in presentation and comprehension) along with the aptitude for thought leadership in data management and analytics
- Expertise with data systems working with massive data sets from various data sources
- Ability to lead a team of Data Engineers
- Develop, deploy, and support real-time, automated, scalable data streams from a variety of sources into the data lake or data warehouse.
- Develop and implement data auditing strategies and processes to ensure data quality; identify and resolve problems associated with large-scale data processing workflows; implement technical solutions to maintain data pipeline processes and troubleshoot failures.
- Collaborate with technology teams and partners to specify data requirements and provide access to data.
- Tune application and query performance using profiling tools and SQL or other relevant query languages.
- Understand business, operations, and analytics requirements for data
- Build data expertise and own data quality for assigned areas of ownership
- Work with data infrastructure to triage issues and drive to resolution
- Experience working with time series databases
- Advanced knowledge of SQL, including the ability to write stored procedures, triggers, analytic/windowing functions, and tuning
- Advanced knowledge of Snowflake, including the ability to write and orchestrate streams and tasks
- Background in Big Data, non-relational databases, Machine Learning and Data Mining
- Experience with cloud-based technologies including SNS, SQS, SES, S3, Lambda, and Glue
- Experience with modern data platforms like Redshift, Cassandra, DynamoDB, Apache Airflow, Spark, or ElasticSearch
- Expertise in Data Quality and Data Governance
Pattern Bioscience develops rapid clinical diagnostics that identify bacterial infections and determine antibiotic resistance. Its system uses single-cell analysis with AI pattern recognition to deliver definitive ID/AST results in about four hours. The product suite includes diagnostic devices, consumables, service contracts, and software for AI analysis. By speeding and improving accuracy, Pattern Bioscience aims to help hospitals reduce inappropriate antibiotic use and combat antibiotic resistance.
Company Size
51-200
Company Stage
Series D
Total Funding
$91.6M
Headquarters
Austin, Texas
Founded
2016
Simplify's Take
What believers are saying
- $43M Series D funding from AMR Action Fund supports FDA 510(k) submission.
- $40.9M BARDA contract accelerates pneumonia and bacteremia panel development.
- Over 1,000 samples enrolled in multi-center trial for Q3 regulatory push.
What critics are saying
- Accelerate Diagnostics' PhenoVue captures market with FDA-cleared 3-hour AST.
- BioFire's FilmArray dominates ICU syndromic testing, sidelining single-pathogen focus.
- Clinical trial failure by mid-2026 exhausts Series D runway, halting launch.
What makes Pattern Bioscience unique
- Digital CultureTM enables culture-free phenotypic ID/AST in four hours.
- Single-cell analysis captures all resistance mechanisms unlike genotypic tests.
- Pneumonia ID/AST Panel targets critically ill patients with FDA Breakthrough Designation.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
Paid Holidays
401(k) Company Match
401(k) Retirement Plan
Health Savings Account/Flexible Spending Account
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 2%2 year growth
↓ -1%Pattern Bioscience has raised $43 million in Series D funding, led by AMR Action Fund, Illumina Ventures, and Omnimed Capital. The funds will support a US multi-center clinical trial and regulatory submission for their Pneumonia ID/AST Panel, which has FDA Breakthrough Device Designation and is backed by a BARDA contract worth up to $40.9 million. Latham & Watkins LLP represented Pattern Bioscience in the transaction.
To quickly develop effective treatments for drug-resistant bacterial infections, Pattern is a leader in the application of single-cell microbiology.
Pattern Bioscience secures $28.7 million in Series C financing to accelerate development of first-of-its-kind infectious disease diagnostic platform
Pattern Bioscience, an Austin, TX-based company which specializes in rapid diagnosis and antibiotic susceptibility testing (AST) for bacterial infections, raised $28.7M in Series C funding.
Including the Series C round, Pattern has now raised $68 million to date, the company said in a statement.